# US 2024/0076311 A1 · Method for synthesizing peptide thioesters and head-to-tail amide cyclic peptide thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0076311 A1
- Document ID: US20240076311A1
- Status: Published application
- Kind: A1
- Application number: 18/259,476
- Filed: 2021-12-27
- Published: 2024-03-07
- Earliest claimed: 2020-12-28
- Assignees: Jiangsu Genscript Biotech Co., Ltd.
- Applicants: Jiangsu Genscript Biotech Co., Ltd.
- Inventors: Zhili Chen; Tongqiang Tao; Baofeng Tan; Xin Zhang
- Web page: https://patentgrep.com/patent/US20240076311A1

## CPC

- C07K 1/113: without change of the primary structure
- C07K 1/04: on carriers {(C07K1/003, C07K1/006 take precedence)}
- C07K 1/061: {using protecting groups}
- C07K 1/086: {containing sulfur}
- C07K 1/1077: {by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method for synthesizing peptide thioesters and a head-to-tail amide cyclic peptide thereof, which belongs to the technical field of chemical pharmaceuticals and fine chemical preparation. The method comprises the following steps: (1) using resin A as a carrier and using a solid-phase synthesis strategy to obtain a resin peptide; (2) cutting the resin to obtain a fully protected peptide; (3) performing an esterification reaction with p-chlorophenyl thiophenol in a TCFH/alkali condensation system to generate p-chlorophenyl thioester; (4) removing the protecting group to obtain a peptide thioester; and (5) further cyclizing to obtain a head-to-tail cyclic peptide. The preparation of the thioester peptide and the head-to-tail amide cyclic peptide provides a simple technical route with wide universality and a high yield, and has a wide range of applications in the technology of chemical pharmaceuticals and fine chemical preparation.

## Claims

### Claim 1

A method for synthesizing a peptide thioester, characterized by comprising the following steps:
(1) preparation of a resin peptide B: using a resin A as a carrier and sequentially coupling corresponding amino acids in an order from the C-terminal to the N-terminal according to a target sequence by means of solid-phase synthesis to obtain a resin peptide B;
(2) preparation of a fully protected peptide C: cleaving the resin from the resin peptide B obtained in step (1) with a first cleavage reagent to obtain a fully protected peptide C;
(3) preparation of a fully protected peptide thioester D: subjecting the fully protected peptide C obtained in step (2) to an esterification reaction with p-chlorothiophenol under the action of a coupling agent of TCFH and an alkali in a solvent to obtain a fully protected peptide thioester D; and
(4) preparation of a peptide thioester E: under the action of a second cleavage reagent, removing a protecting group from the fully protected peptide thioester D obtained in step (3) to obtain a peptide thioester E,
wherein the peptide is a peptide chain and PG1 is all the protecting groups on a side chain of the peptide chain; and PG2 is a protecting group at the N-terminal of the peptide chain.

### Claim 2 (depends on 1)

The method according to claim 1, characterized in that in step (1), the PG2 is Boc, the peptide chain is a straight chain, and a procedure for synthesizing the resin peptide B is that the last amino acid of the coupling is a Boc-protected amino acid or an N-terminal Boc protection of the peptide chain is performed by means of di-tert-butyl dicarbonate.

### Claim 3 (depends on 1)

The method according to claim 1, characterized in that in step (2), the first cleavage reagent is a dichloromethane solution of trifluoroisopropanol, a volume fraction of the trifluoroisopropanol in the dichloromethane is 10%-90%, and the cleavage is performed for 1-5 times with each cleavage time of 0.5 h-6 h.

### Claim 4 (depends on 3)

The method according to claim 3, characterized in that the volume fraction of the trifluoroisopropanol in the dichloromethane is 33%; and the cleavage is performed for 3 times with each cleavage time of 1 h.

### Claim 5 (depends on 1)

The method according to claim 1, characterized in that in step (3), the alkali is selected from at least one of DIPEA or NMI; and a molar ratio of the fully protected peptide C, the p-chlorothiophenol, the TCFH, and the alkali is 1:(1-2):(1-3):(2-5).

### Claim 6 (depends on 5)

The method according to claim 5, characterized in that the alkali is NMI, and the molar ratio of the fully protected peptide C, the p-chlorothiophenol, the TCFH, and the alkali is 1:1.2:1.5: 4.

### Claim 7 (depends on 1)

The method according to claim 1, characterized in that in step (3), the solvent is one or more of DMF, DMSO, or DMA; and a concentration of the fully protected peptide C in the solvent is 0.01 M-0.2 M.

### Claim 8 (depends on 7)

The method according to claim 7, characterized in that the solvent is DMF, and the concentration of the fully protected peptide C in the solvent is 0.01 M-0.2 M, preferably, 0.1 M.

### Claim 9 (depends on 1)

The method according to claim 1, characterized in that in step (3), the coupling reaction is performed for a time of 4 h-24 h, preferably, 16 h-24 h, more preferably, 16 h.

### Claim 10 (depends on 9)

The method according to claim 9, characterized in that the coupling reaction is performed at a temperature of 20° C-100° C., preferably, 25° C-50° C., more preferably, 30° C.

### Claim 11 (depends on 1)

The method according to claim 1, characterized in that in step (4), the second cleavage reagent is a mixed solution of one or more of EDT, phenol, thioanisole or H2O with TFA.

### Claim 12 (depends on 11)

The method according to claim 11, characterized in that the second cleavage reagent is a mixed solution of the TFA, the EDT, the phenol, the thioanisole, and the H2O, and a volume ratio of the TFA, the EDT, the phenol, the thioanisole, and the H2O in the mixed solution is (50-95):(1-12.5):(1-12.5):(1-12.5):(1-12.5), preferably, 87.5:5:2.5:2.5:2.5.

### Claim 13 (depends on 1)

A method for synthesizing a head-to-tail amide cyclic peptide, characterized by comprising the following steps:
(1) preparing a peptide thioester E by a method according to claim 1; and
(2) under the action of an alkali, cyclizing the peptide thioester E prepared in step (1) in a solvent to obtain a head-to-tail amide cyclic peptide F,
wherein the peptide is a peptide chain.

### Claim 14 (depends on 13)

The method according to claim 13, characterized in that in step (2), the alkali is one or more of DIPEA, DBU, imidazole, or NMI, and a molar ratio of the peptide thioester E to the alkali is 1:(2-5).

### Claim 15 (depends on 13)

The method according to claim 13, characterized in that in step (2), the solvent is one or more of DMF, DMSO, or DCM; and a concentration of the peptide thioester E in the solvent is 0.001 M-0.01 M.

### Claim 16 (depends on 13)

The method according to claim 13, characterized in that in step (2), the alkali is DIPEA; a molar ratio of the peptide thioester E to the alkali is 1:3; and the solvent is DMF, and a concentration of the peptide thioester E in the solvent is 0.0025.
